Clinical Trial

Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
We compared the time consumed for goal-directed management of hypofibrinogemia using two strategies during liver transplant (LT) surgery: a conventional cryoprecipitate-based strategy versus a lyophilized fibrinogen concentrate-based strategy
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-16; most recent amendment 2025-07-16.
Trial Details
NCT Number NCT06144112
Lead Sponsor Konkuk University Medical Center
Collaborators: Samsung Medical Center
Conditions Liver Diseases
Enrollment 92 participants
Start Date 2025-09-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-20